Oligomeric aggregation inhibitor
Anle138b is a oligomeric aggregation inhibitor that inhibits formation of pathological prion protein (PrPSc) and α-synuclein aggregates
in vitro
. Anle138b prevents accumulation of PrPSc in brain and spleen, and prolongs survival of prion-infected mice. Anle138b exhibits neuroprotective effects in a Parkinson's disease mouse model and improves motor performance in an α-synucleinopathy model. Orally bioavailable and brain penetrant.
| Marque | Tocris |
|---|---|
| Réf. B-LABO | BL-RE-125126 |
| Réf. fabricant | 18765406 |
| Quantité | 25 mg |
| Formule moléculaire | C<sub>16</sub>H<sub>11</sub>BrN<sub>2</sub>O<sub>2</sub> |
| Poids de la formule | 343.18 |
| Type de produit | Inhibitor |
| Pureté | 98% |
